NCHC

National Coalition On Health Care

  • About Us
    • Members and Supporters
    • Board of Directors
    • Staff
    • Annual Reports
  • Policy
    • COVID-19 Response
    • Make Prescription Drugs More Affordable
    • Eliminate Surprise Medical Billing
    • Make Health Care Affordable and Accessible
    • Promote a High-Value Health Care System that Supports Vulnerable Populations
  • Blog
  • Events
  • Newsroom
    • Press Releases
    • NCHC In The News
    • Policy Correspondence
    • Fact Sheets & Issue Briefs
  • Get Involved
    • Become a Member
    • Become a Funder
  • Contact Us
  • Special Projects
    • NCHC Round Table Series on Health Care Affordability and Transparency

Justifying After the Fact Is Not Justification

October 22, 2014 By Larry McNeely

Tweet
Share

By John Rother

A recent study funded by the National Institute on Aging compared Gilead’s Sovaldi to previous Hepatitis C treatments on a cost-benefit basis and concluded that Sovaldi offered value. This study is a perfect example of getting the answer only to the question you ask.

It is true that Sovaldi is more efficacious than previous therapies. However, that is far from the full picture.

What the study should have asked is whether or not the price Gilead set for the therapy is appropriate for all patients–even asymptomatic patients–and whether or not such a large portion of potential societal value should accrue to one company. Other studies, such as one conducted by the highly-respected California Technology Assessment Forum, concluded that Sovaldi does not offer reasonable value to the health care system.

However, the study highlights a bigger problem: the fact that these studies are only offered after a drug is priced and have no bearing on the pricing decision. Gilead’s President, Dr. John Milligan, has made it quite clear that Gilead doesn’t price based on value, but instead by looking at the price of preceding products. What we need is a system where there is a more rigorous up-front economic and social evaluation of expensive new therapies. Without that evaluation, we end up with what we have in Sovaldi and Harvoni–monopolistic pricing where there is an attempt to justify legitimacy after the fact.

Filed Under: Blog

Mission

To bring together key stakeholders in order to achieve an affordable, high-value health care system for patients and consumers, for employers and other payers, and for taxpayers.

Signup for NCHC Newsletter

NCHC Recent Policy Correspondence

  • The Budget Reconciliation Process and NCHC Priorities in 2021
  • NCHC STATEMENT ON BICAMERAL AND BIPARTISAN SURPRISE BILLING LEGISLATION, “NO SURPRISES ACT,”
  • NCHC STATEMENT ON PART D REBATE SAFE HARBOR REPEAL AND “MOST FAVORED NATION” DEMONSTRATION
  • NCHC Statement On The Trump Administration’s “Most-Favored-Nation” Drug Pricing Executive Order
  • NCHC Statement on the Trump Administration’s Executive Orders
...More Policy Correspondence

National Coalition on Health Care

About Us

The National Coalition on Health Care (NCHC) was formed more than two decades ago to help achieve comprehensive health system change. We aim to be a leader in promoting a healthy population and a more effective, efficient and responsive health system that provides quality care for all. NCHC is a nonpartisan, nonprofit organization of organizations. Our growing Coalition represents more than 80 participating organizations, including medical societies, businesses, unions, health care providers, faith-based associations, pension and health funds, insurers, and groups representing consumers, patients, women, minorities and persons with disabilities. … Read More...

Interim CEO

Shawn Martin

CHAIRMAN

Jack Lewin
Principal and Founder
Lewin and Associates, LLC

MISSION

To bring together key stakeholders in order to achieve an affordable, high-value health care system for patients and consumers, for employers and other payers, and for taxpayers.

CONTACT US

900 16th Street NW, Suite 400
Washington, DC 20006
contactus@nchc.org

Connect With NCHC

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Recent News & Posts

  • All Payer Claims Databases and Health Care Affordability
  • National Coalition on Health Care and West Health, The Burden of High Drug Prices on Communities of Color
  • NCHC ANNOUNCES RETIREMENT OF PRESIDENT JOHN ROTHER
  • NCHC & West Health Hill Briefing: The Burden of High Drug Prices Among Communities of Color
  • Reference Pricing: A Bipartisan Solution to High Hospital Prices?

Recent Tweets

Tweets by NC_HC

Copyright © 2022 · Outreach Pro Theme on Genesis Framework · WordPress · Log in